Related Experiment Video
Updated: Aug 9, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C
Anastasia Metlitskaya1, Teymur Kazakov, Aigar Kommer
1Institute of Molecular Genetics, Russian Academy of Sciences, Moscow 123182, Russia.
Abstract:
Microcin C is a ribosome-synthesized heptapeptide that contains a modified adenosine monophosphate covalently attached to the C-terminal aspartate. Microcin C is a potent inhibitor of bacterial cell growth. Based on the in vivo kinetics of inhibition of macromolecular synthesis, Microcin C targets translation, through a mechanism that remained undefined. Here, we show that Microcin C is a subject of specific degradation inside the sensitive cell. The product of degradation, a modified aspartyl-adenylate containing an N-acylphosphoramidate linkage, strongly inhibits translation by blocking the function of aspartyl-tRNA synthetase.
Insights
Microcin C, an antibacterial peptide, inhibits bacterial growth by targeting translation. Its degradation product specifically blocks aspartyl-tRNA synthetase, halting protein synthesis.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Microcin C is a ribosome-synthesized heptapeptide with a unique modified adenosine monophosphate.
- It is known to be a potent inhibitor of bacterial cell growth, targeting translation.
- The precise mechanism of Microcin C's inhibition of bacterial translation remained undefined.
Purpose of the Study:
- To elucidate the undefined mechanism by which Microcin C inhibits bacterial translation.
- To identify the specific molecular target and degradation products of Microcin C within sensitive cells.
Main Methods:
- In vivo kinetic analysis of macromolecular synthesis inhibition.
- Characterization of Microcin C degradation products within bacterial cells.
- Biochemical assays to assess the inhibitory activity of degradation products on translation machinery.
Main Results:
- Microcin C undergoes specific degradation within sensitive bacterial cells.
- The primary degradation product is a modified aspartyl-adenylate with an N-acylphosphoramidate linkage.
- This aspartyl-adenylate derivative potently inhibits bacterial translation by blocking aspartyl-tRNA synthetase activity.
Conclusions:
- Microcin C's antibacterial activity is mediated by its degradation product.
- The degradation product acts as a specific inhibitor of aspartyl-tRNA synthetase, a crucial enzyme in protein synthesis.
- This study defines the mechanism of action for Microcin C, revealing a novel strategy for bacterial translation inhibition.
Related Concept Videos
tRNA Activation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Inhibitors of Bacterial Protein Synthesis
Amino Acid Catabolism
Inhibitors of Gram-positive Cell Wall Synthesis
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...

